Moderna, Inc. - Common Stock (MRNA)

Historical Holders from Q4 2018 to Q1 2025

Symbol
MRNA on Nasdaq
CUSIP
60770K107
Type / Class
Equity / Common Stock
Shares outstanding
385M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
276M
Holdings value
$11.5B
% of all portfolios
0.009%
Grand Portfolio weight change
+0.001%
Number of holders
729
Number of buys
296
Number of sells
-407
Average Value change %
+0%
Average buys %
+0.004%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Moderna, Inc. - Common Stock (MRNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 10.1% $1.1B 38.9M BAILLIE GIFFORD & CO Dec 31, 2024

Institutional Holders of Moderna, Inc. - Common Stock (MRNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 4.38M $124M +$38.7M $28.35 111
2024 Q4 276M $11.5B +$498M $41.58 729
2024 Q3 257M $17.1B -$821M $66.83 765
2024 Q2 262M $31.1B +$416M $118.75 937
2024 Q1 259M $27.6B +$210M $106.56 890
2023 Q4 257M $25.5B +$1.23B $99.45 843
2023 Q3 243M $25.1B -$391M $103.29 850
2023 Q2 244M $29.6B -$850M $121.50 926
2023 Q1 245M $37.6B +$87.6M $153.58 976
2022 Q4 248M $44.5B +$357M $179.62 1,029
2022 Q3 242M $28.6B +$337M $118.25 857
2022 Q2 244M $34.8B -$410M $142.85 940
2022 Q1 245M $42.2B +$557M $172.26 963
2021 Q4 241M $61B +$683M $253.98 1,062
2021 Q3 243M $93.4B +$6.74B $384.86 1,113
2021 Q2 208M $48.8B +$5.17B $234.98 866
2021 Q1 189M $24.7B +$2.71B $130.95 753
2020 Q4 168M $17.6B -$523M $104.47 672
2020 Q3 205M $14.5B -$1.02B $70.75 526
2020 Q2 217M $14B +$1.64B $64.21 469
2020 Q1 190M $5.69B +$497M $29.95 274
2019 Q4 169M $3.31B +$261M $19.56 152
2019 Q3 105M $1.68B +$425M $15.92 129
2019 Q2 143M $2.1B +$129M $14.64 125
2019 Q1 138M $2.8B +$99.8M $20.35 101
2018 Q4 134M $2.02B +$2.02B $15.27 74